{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-003380","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2024-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.300820+00:00","generated_at":"2026-06-07T03:03:58.445525+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Soleno Therapeutics sets 2024 executive compensation: CEO salary $640K, bonus $500K, equity grants","bullets":["CEO Bhatnagar 2024 salary $640K, 2023 bonus $500K, equity: 100K options (50% cliff 1yr) + 150K RSUs (quarterly vest).","CFO Mackaness salary $460K, bonus $240K, equity: 37K options + 56K RSUs.","VP Regulatory Hirano salary $375K, bonus $153K, equity: 16K options + 24K RSUs.","Salary increases effective Jan 1, 2024; bonuses for FY2023.","Options vest 50% on first anniversary, then monthly; RSUs vest quarterly in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-003380","json":"https://secwatch.observer/filing/0001193125-24-003380.json","markdown":"https://secwatch.observer/filing/0001193125-24-003380.md","text":"https://secwatch.observer/filing/0001193125-24-003380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524003380/0001193125-24-003380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524003380/d111987d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T03:03:58.445525+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}